MedPath

Randomize comparison of Vaginal suppository containing zhumeria majdae essential oil with vaginal clotrimazole versus placebo vaginal suppository with vaginal clotrimazole for vulvovaginal candidiasis treatment

Phase 1
Recruiting
Conditions
candidiasis vulvovaginit.
Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
N77.1
Registration Number
IRCT20150706023084N12
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

women aged 18 to 50 years
Married
lack of sensitivity to the plant compounds of Zhumeria majdae
lack of sensitivity to clotrimazole
signature the consent form to participate in the study Exclusioncriteria
Diagnosis of vaginal candidiasis infection

Exclusion Criteria

pregnancy and lactation
menopause
underlyingdiseases
forgetting a dose or more
patientunwillingness to continue treatme
menstruation during the study
abnormal uterine bleeding
sensitivity to Zhumeria majdae
sensitivity to clotrimazole

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Itching. Timepoint: Start of study - 7 days after the start of the study. Method of measurement: Questionnaire -Complete a checklist to evaluate the symptoms of candidal vaginitis and then compare thefrequency of symptoms of candidal vaginitis within and between the two treatment groups.;Discharge. Timepoint: Start of study - 7 days after the start of the study. Method of measurement: Questionnaire.;Inflammation. Timepoint: Start of study - 7 days after the start of the study. Method of measurement: Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath